We are live on !
Find out more
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.94%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.64B
AUM Growth
+$244M
(+10%)
Cap. Flow
+$55.9M
Cap. Flow % of AUM
Cap. Flow %
2.11%
Top 10 Holdings %
Top 10 Hldgs %
30.38%
Holding
727
New
40
Increased
101
Reduced
241
Closed
72
Avg Time Held
3.7
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Growth ETF
EFG
|
+$38M |
| 2 |
NVIDIA
NVDA
|
+$32.9M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$31.9M |
| 4 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$17.1M |
| 5 |
Eli Lilly
LLY
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$12.2M |
| 2 |
PayPal
PYPL
|
+$12.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11.6M |
| 4 |
Adobe
ADBE
|
+$10.7M |
| 5 |
Becton Dickinson
BDX
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Miscellaneous | 15.82% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.67% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $10.9K | ﹤0.01% |
186
| – | – |
2021 Q1
12 quarters
|
|
577
DELISTED
Roku
ROKU
| $10.4K | ﹤0.01% |
+160
| New | +$12.4K |
2024 Q1
0 quarters
|
|
578
Occidental Petroleum
OXY
$58.7B
| $9.7K | ﹤0.01% |
150
| – | – |
2021 Q4
9 quarters
|
|
579
Regeneron Pharmaceuticals
REGN
$98.8B
| $9.6K | ﹤0.01% |
10
-147
| -94% | -$140K |
2021 Q4
9 quarters
|
|
580
Manulife Financial
MFC
$72.8B
| $9.45K | ﹤0.01% |
378
| – | – |
2021 Q1
12 quarters
|
|
581
Brookfield Renewable
BEP
$9.08B
| $9.34K | ﹤0.01% |
402
| – | – |
2022 Q2
7 quarters
|
|
582
KeyCorp
KEY
$22.7B
| $9.33K | ﹤0.01% |
590
| – | – |
2022 Q2
7 quarters
|
|
583
Unitil
UTL
$1.03B
| $9.21K | ﹤0.01% |
176
| – | – |
2021 Q4
9 quarters
|
|
584
Exelon
EXC
$47.9B
| $8.72K | ﹤0.01% |
+232
| New | +$8.29K |
2024 Q1
0 quarters
|
|
585
State Street SPDR Portfolio Mortgage Backed Bond Index ETF
SPMB
$6.88B
| $8.69K | ﹤0.01% |
400
| – | – |
2022 Q1
8 quarters
|
|
586
iShares Select U.S. REIT ETF
ICF
$2.05B
| $8.66K | ﹤0.01% |
150
-25
| -14% | -$1.43K |
2021 Q4
9 quarters
|
|
587
Cognex
CGNX
$8.42B
| $8.48K | ﹤0.01% |
+200
| New | +$7.79K |
2024 Q1
0 quarters
|
|
588
Geron
GERN
$623M
| $8.25K | ﹤0.01% |
2,500
| – | – |
2023 Q2
3 quarters
|
|
589
DELISTED
Kenvue
KVUE
| $7.92K | ﹤0.01% |
369
| – | – |
2023 Q3
2 quarters
|
|
590
Spotify
SPOT
$126B
| $7.92K | ﹤0.01% |
30
| – | – |
2021 Q4
9 quarters
|
|
591
Schwab International Equity ETF
SCHF
$67.5B
| $7.8K | ﹤0.01% |
+400
| New | +$7.48K |
2024 Q1
0 quarters
|
|
592
Regenxbio
RGNX
$505M
| $7.8K | ﹤0.01% |
370
| – | – |
2021 Q4
9 quarters
|
|
593
Kyndryl
KD
$3.66B
| $7.77K | ﹤0.01% |
357
-60
| -14% | -$1.28K |
2022 Q1
8 quarters
|
|
594
Dimensional US Marketwide Value ETF
DFUV
$16B
| $7.24K | ﹤0.01% |
177
-200
| -53% | -$7.64K |
2023 Q2
3 quarters
|
|
595
Chewy
CHWY
$9.05B
| $7K | ﹤0.01% |
+440
| New | +$7.9K |
2024 Q1
0 quarters
|
|
596
Brookfield Infrastructure
BIPC
$4.87B
| $6.74K | ﹤0.01% |
187
| – | – |
2021 Q4
9 quarters
|
|
597
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$21B
| $6.56K | ﹤0.01% |
137
| – | – |
2023 Q4
1 quarter
|
|
598
Align Technology
ALGN
$11.9B
| $6.56K | ﹤0.01% |
20
| – | – |
2021 Q4
9 quarters
|
|
599
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$39.1B
| $6.01K | ﹤0.01% |
120
| – | – |
2022 Q2
7 quarters
|
|
600
Spire Global
SPIR
$362M
| $6K | ﹤0.01% |
500
| – | – |
2023 Q4
1 quarter
|
|
Similar funds
Cambridge Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Trust held 727 positions worth $2.64B, up 10% from $2.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Cambridge Trust's Q1 2024 filing shows 40 new, 101 increased, 241 reduced and 72 closed positions. Its largest new stake was Best Buy: 93,973 shares worth $7.71M. The largest sale was JPMorgan Equity Premium Income ETF, an estimated $12.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Financials.
- Cambridge Trust's largest Q1 2024 buy was Best Buy: 93,973 shares worth $7.71M.
- Cambridge Trust added most to iShares MSCI EAFE Growth ETF in Q1 2024, an estimated $38M increase.
- Cambridge Trust's biggest Q1 2024 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $12.2M.
- Cambridge Trust fully exited Marvell Technology in Q1 2024, selling an estimated $302K.
- Cambridge Trust's ten largest holdings make up 30% of its $2.64B portfolio in Q1 2024.
- Cambridge Trust opened 40 new positions and closed 72 in Q1 2024.
- Cambridge Trust's portfolio value rose 10% quarter-over-quarter to $2.64B.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.